Home Commercial Roche Looking to Shutter its Vacaville Plant Valued at $700MM
CommercialFinanceINDUSTRY newsLife Science

Roche Looking to Shutter its Vacaville Plant Valued at $700MM

Share
Share

By The Registry Staff Roche Holding AG, the renowned Swiss drugmaker, has announced its intention to divest its drug manufacturing facility in Vacaville, California, located at 1000 New Horizons Way. The company aims to sell the plant, which currently employs around 800 individuals, or alternatively, shut it down by 2029, as revealed in internal communications […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Regional Operator Acquires 34-Unit Mission Villa Memory Care Community in Daly City for $10.65MM

A regional owner-operator has acquired Mission Villa Senior Living, a 34-unit memory...

Hines Hands Reins to Third Generation as Adam Hines Joins Sister Laura Hines-Pierce as Co-CEO

Hines is moving its third generation into full command of the $91...

Downtown Merced’s Bullet-Train Station Rides on Legal Demand, $2.4B Contract Option and $1B Savings Pitch

A legal demand from California Rural Legal Assistance and nine Valley groups,...